Verisk Analytics, Inc.

VRSK

Verisk Analytics provides data analytics and risk assessment services primarily to the insurance, healthcare, and financial services industries.
It is a dominant provider whose value lies in its extensive proprietary data sets and sophisticated analytical models that help clients quantify and manage risk.

$207.57 +4.93 (+2.43%)

Updated: February 27, 2026, 16:00 EST

Analyzed by Rockflow Bobby Quantitative Model āœ“ Updated Daily

Investment Opinion: Should I buy VRSK Today?

Based on a comprehensive review of VRSK's technical, fundamental, valuation, and risk profile, the stock presents a cautious picture that leans towards a HOLD recommendation at this time, rather than a buy.

Technically, the stock is in a weak position, having underperformed the market significantly and showing downside volatility that is concerning despite its low beta. While there is modest recovery potential from current levels, the sustained downward pressure and substantial distance from recent highs indicate lingering bearish sentiment. Fundamentally, the company displays a stark dichotomy; its core operational profitability is robust, but this is heavily overshadowed by a highly leveraged balance sheet and weak cash flow relative to its substantial debt. The high return on equity, while impressive, is artificially boosted by this leverage rather than pure operational excellence.

Valuation remains the most significant hurdle, with metrics like a P/E near 40 and a negative PEG ratio suggesting the stock is priced for perfection despite recent profitability pressures. The combination of high valuation, significant financial leverage, and weak price momentum creates a scenario where the risk currently outweighs the potential reward. Investors may want to wait for a more attractive entry point or signs of improved fundamental stability, particularly regarding debt management and sustained earnings growth that can justify its premium multiples.

*Disclaimer: This is not investment advice, for reference only.*

CTA Banner

VRSK 12-Month Price Forecast

RockFlow Model Forecast: Three Scenarios for 2026

Based on the provided analysis, here is a 12-month outlook for VRSK:

Over the next 12 months, the key catalyst for VRSK hinges on its ability to demonstrate sustained earnings growth that can justify its premium valuation, coupled with tangible progress in managing its substantial debt load to improve cash flow stability. However, the primary risks are significant, including its high financial leverage, pricey valuation multiples that leave little room for error, and persistent weak technical momentum indicating lingering bearish sentiment. Given the lack of a specific analyst target and the assessment that risk currently outweighs reward, investors should expect a period of consolidation with a neutral outlook and a cautious HOLD recommendation, suggesting potential for only modest recovery from the current price of $207.57.

*Disclaimer: This is not investment advice, for reference only.*

Wall Street Consensus

Most Wall Street analysts are optimistic about Verisk Analytics, Inc.'s 12-month outlook, with consensus target around $207.57, indicating expected upside potential.

Average Target
$207.57
20 analysts
Implied Upside
+0%
vs. current price
Analyst Count
20
covering this stock
Price Range
$166 - $270
Analyst target range
Buy Buy
10 (50%)
Hold Hold
9 (45%)
Sell Sell
1 (5%)

Bulls vs Bears: VRSK Investment Factors

Overall, VRSK has investment potential but also faces challenges. Here are key factors to weigh before investing.

Bullish Bullish
  • Accelerated Share Buyback: Company is repurchasing $1.5B in stock through 2026, signaling confidence.
  • Strategic Refocus on Core Business: Company is focusing on its profitable core insurance analytics market.
  • Wall Street Moderate Buy Rating: Wall Street consensus maintains a 'Moderate Buy' rating on the stock.
  • Debt Refinancing for Flexibility: Issued $1B in new debt to repay higher-cost loans used for buybacks.
Bearish Bearish
  • Post-Earnings Stock Decline: Stock fell following the release of its quarterly results.
  • Recent Underperformance vs. S&P 500: The stock has been underperforming the broader S&P 500 index.
  • Investor Concerns Over Performance: Market discussions show concerns about the stock's recent decline.
  • Valuation Questions Remain: Debate continues on whether the stock is fairly priced after recent moves.
Reward Banner

VRSK Technical Analysis

VRSK has demonstrated weak medium-term performance with significant downside volatility compared to market benchmarks. The stock remains substantially below its annual peak despite being well above yearly lows, reflecting a partial recovery from steep declines.

The stock declined 5.23% over one month and 6.99% over three months, significantly underperforming the broader market by 11.08 percentage points during this period. Despite its below-average beta of 0.80, VRSK has exhibited greater downside volatility than typical for its risk profile.

Currently trading at $207.57, VRSK sits in the lower-middle portion of its 52-week range, approximately 28% above the low but 36% below the high. While not severely oversold, the stock shows modest recovery potential given its substantial distance from recent highs and maximum drawdown of -47.26%.

šŸ“Š Beta
0.80
0.80x market volatility
šŸ“‰ Max Drawdown
-47.3%
Largest decline past year
šŸ“ˆ 52-Week Range
$165-$323
Price range past year
šŸ’¹ Annual Return
-30.1%
Cumulative gain past year
Period VRSK Return S&P 500
1m -5.2% -1.4%
3m -7.0% +4.1%
6m -23.4% +7.5%
1y -30.1% +15.4%
ytd -6.1% +0.4%

VRSK Fundamental Analysis

Revenue & Profitability: VRSK demonstrated modest sequential revenue growth in Q4 2025, increasing to $778.8 million from $768.3 million in Q3. However, profitability saw pressure, with the net profit margin declining to 25.3% from 29.4% the prior quarter, primarily driven by a significant increase in total other expenses. The operating profit margin remained robust at 43.6%, indicating strong core operational performance.

Financial Health: The company carries a high debt load, evidenced by a debt-to-equity ratio of 16.3 and a total debt to capitalization of 94.2%. While the interest coverage ratio of 6.0 suggests earnings are sufficient to service interest obligations, the cash flow to debt ratio is weak at 0.07, indicating limited annual cash flow relative to total debt. The current ratio of 1.2 reflects adequate short-term liquidity.

Operational Efficiency: VRSK exhibits excellent returns for shareholders, with a remarkably high return on equity of 63.8%, significantly amplified by its substantial financial leverage. However, asset utilization appears less efficient, with a low asset turnover of 0.13. The 33.5-day cash conversion cycle demonstrates effective management of working capital, efficiently converting receivables and payables into cash.

Quarterly Revenue
N/A
2025-12
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A%
Latest Quarter
Free Cash Flow
$0.8B
Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

RockFlow Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

Try Now & Get Tesla Stock Reward

Valuation Analysis: Is VRSK Overvalued?

VRSK appears significantly overvalued based on its price-to-earnings ratios. The current TTM PE of 40.58 and forward PE of nearly 39.4 indicate investors are paying a substantial premium for its earnings. Supporting this view, the extremely high PB ratio of 91.16 and negative PEG ratio of -3.19 suggest growth expectations are not justifying the current valuation multiples.

Without specific industry average data for comparison, a definitive peer evaluation cannot be established. However, VRSK's valuation metrics, particularly the PE ratios exceeding 39 and EV/EBITDA above 81, would typically place it at the upper end of most industry spectrums. The negative PEG ratio presents an additional concern relative to standard valuation frameworks across most comparable sectors.

PE
40.6x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 17Ɨ-130Ɨ
vs. Industry Avg
N/A
Industry PE ~N/AƗ
EV/EBITDA
81.2x
Enterprise Value Multiple

Investment Risk Disclosure

Volatility Risk: With a beta of 0.804, VRSK exhibits moderately lower volatility than the broader market, suggesting it is somewhat insulated from systematic market swings. However, the significant one-year maximum drawdown of -47.26% indicates the stock has experienced substantial price declines from recent peaks, pointing to notable downside risk even with its lower beta.

Other Risks: The notable absence of reported short interest implies that there is little to no speculative bearish sentiment targeting the stock, which can be viewed positively. This lack of short pressure, combined with VRSK's large market capitalization, generally indicates strong liquidity and investor confidence, though it does not eliminate fundamental business or sector-specific risks.

FAQs

Is VRSK a good stock to buy?

Neutral to slightly bearish for now. While VRSK possesses strong operational profitability and shareholder returns, it is significantly overvalued with high PE ratios and a negative PEG, suggesting the price already reflects its strengths. Recent underperformance and margin pressure add to near-term concerns. This stock may appeal to long-term, growth-oriented investors who are comfortable with its high valuation and debt load, but it presents little compelling value for short-term or value-focused investors.

Is VRSK stock overvalued or undervalued?

Based on current metrics, VRSK appears significantly overvalued. Its PE ratio of 40.6 and forward PE of 39.4 are extremely high relative to typical market standards, and the negative PEG ratio suggests declining growth expectations. The astronomical PB ratio of 91.2 indicates the market price far exceeds the company's book value, while the PS ratio of 12.5 reflects a high premium for sales. Although VRSK maintains strong operational profitability, its declining net margins and highly leveraged balance sheet (94% debt-to-capitalization) don't justify these premium valuation multiples.

What are the main risks of holding VRSK?

Based on the provided information, here are the key risks of holding VRSK, ordered by importance:

1. High Financial Leverage Risk: The company's extremely high debt-to-capitalization ratio of 94.2% creates significant financial risk, making it vulnerable to rising interest rates and potentially limiting its strategic flexibility. 2. Notable Downside Volatility Risk: Despite a low beta of 0.80, the stock's maximum drawdown of -47.26% and recent significant underperformance versus the market indicate it possesses substantial, investor-specific downside risk. 3. Profit Margin Compression Risk: The recent quarter-over-quarter decline in net profit margin from 29.4% to 25.3%, driven by a significant increase in non-operating expenses, signals potential pressure on bottom-line profitability.

What is the price forecast for VRSK in 2026?

Based on the current financial profile, my 2026 forecast for VRSK anticipates a continued focus on leveraging its core operational strengths to navigate its high leverage.

Target Price & Drivers: I project a base case target range of $220-$240 by 2026, with a bull case of $260+ contingent on successful debt management. Key growth drivers will be: 1) Sustained high operating margins from its robust core operations, 2) Strategic deleveraging to improve cash flow and reduce financial risk, and 3) Steady, modest revenue expansion in its niche markets.

Assumptions & Uncertainty: This forecast assumes that VRSK can maintain its strong operational profitability while making gradual progress on its debt load without significant economic disruption. However, the outlook carries high uncertainty; the stock's performance is highly sensitive to interest rate changes and any misstep in managing its substantial leverage could severely limit upside potential.

*Disclaimer: This is not investment advice, for reference only.*